Consequences of Hypoglycemia on Intensive Care Unit (ICU) Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00662922 |
Recruitment Status :
Completed
First Posted : April 21, 2008
Last Update Posted : January 11, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Critical Illness |
Study Type : | Observational |
Actual Enrollment : | 74 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | Does Hypoglycemia Under Intensive Insulin Therapy During Critical Illness Lead to Neurocognitive Dysfunction |
Study Start Date : | April 2008 |
Actual Primary Completion Date : | September 2008 |
Actual Study Completion Date : | September 2008 |

Group/Cohort |
---|
1
patients with hypoglycemia during intensive care
|
2
patients without hypoglycemia during intensive care
|
- neurocognitive function [ Time Frame: 1 year after ICU discharge ]
- neurocognitive function [ Time Frame: 2,3, and 4 years after ICU discharge ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- all patients
Exclusion Criteria:
- clinical diagnosis of diabetes mellitus
- brain injury of any kind prior to or upon ICU-admission
- pre-existing mental or psychiatric disorder
- terminal kidney or liver failure prior admission
- drug abuse,
- CPR > 5 min
- HIV
- Lues

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00662922
Germany | |
Department of Anesthesiology and Intensive Care, University Hospital Münster | |
Münster, Germany, D-48149 |
Principal Investigator: | Björn Ellger, MD | Department of Anesthesiology and Intensive Care Medicine, University Hospital Muenster |
Responsible Party: | Principle investigator, Dr. Björn Ellger, Department of Anesthesiology and Intensive Care Medicine |
ClinicalTrials.gov Identifier: | NCT00662922 |
Other Study ID Numbers: |
05-AnIt-07 |
First Posted: | April 21, 2008 Key Record Dates |
Last Update Posted: | January 11, 2010 |
Last Verified: | January 2010 |
critical illness hypoglycemia neurocognitive dysfunction intensive insulin therapy |
Hypoglycemia Critical Illness Glucose Metabolism Disorders |
Metabolic Diseases Disease Attributes Pathologic Processes |